These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


256 related items for PubMed ID: 14670183

  • 1. TRAIL activates a caspase 9/7-dependent pathway in caspase 8/10-defective SK-N-SH neuroblastoma cells with two functional end points: induction of apoptosis and PGE2 release.
    Zauli G, Milani D, Rimondi E, Baldini G, Nicolin V, Grill V, Secchiero P.
    Neoplasia; 2003; 5(5):457-66. PubMed ID: 14670183
    [Abstract] [Full Text] [Related]

  • 2. JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation.
    MacFarlane M, Cohen GM, Dickens M.
    Biochem J; 2000 May 15; 348 Pt 1(Pt 1):93-101. PubMed ID: 10794718
    [Abstract] [Full Text] [Related]

  • 3. The involvement of reactive oxygen species (ROS) and p38 mitogen-activated protein (MAP) kinase in TRAIL/Apo2L-induced apoptosis.
    Lee MW, Park SC, Yang YG, Yim SO, Chae HS, Bach JH, Lee HJ, Kim KY, Lee WB, Kim SS.
    FEBS Lett; 2002 Feb 13; 512(1-3):313-8. PubMed ID: 11852102
    [Abstract] [Full Text] [Related]

  • 4. Role of caspases in dexamethasone-induced apoptosis and activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in human eosinophils.
    Zhang JP, Wong CK, Lam CW.
    Clin Exp Immunol; 2000 Oct 13; 122(1):20-7. PubMed ID: 11012613
    [Abstract] [Full Text] [Related]

  • 5. Differential response of neuroblastoma cells to TRAIL is independent of PI3K/AKT.
    Efron PA, Chen MK, Iyengar M, Dai W, Nagaram A, Beierle EA.
    J Pediatr Surg; 2006 Jun 13; 41(6):1072-80. PubMed ID: 16769337
    [Abstract] [Full Text] [Related]

  • 6. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.
    Eggert A, Grotzer MA, Zuzak TJ, Wiewrodt BR, Ho R, Ikegaki N, Brodeur GM.
    Cancer Res; 2001 Feb 15; 61(4):1314-9. PubMed ID: 11245427
    [Abstract] [Full Text] [Related]

  • 7. Modulation of ROS/MAPK signaling pathways by okadaic acid leads to cell death via, mitochondrial mediated caspase-dependent mechanism.
    Ravindran J, Gupta N, Agrawal M, Bala Bhaskar AS, Lakshmana Rao PV.
    Apoptosis; 2011 Feb 15; 16(2):145-61. PubMed ID: 21082355
    [Abstract] [Full Text] [Related]

  • 8. Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells.
    Milani D, Zauli G, Rimondi E, Celeghini C, Marmiroli S, Narducci P, Capitani S, Secchiero P.
    J Neurochem; 2003 Jul 15; 86(1):126-35. PubMed ID: 12807432
    [Abstract] [Full Text] [Related]

  • 9. Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.
    Johnsen JI, Pettersen I, Ponthan F, Sveinbjørnsson B, Flaegstad T, Kogner P.
    Int J Oncol; 2004 Dec 15; 25(6):1849-57. PubMed ID: 15547726
    [Abstract] [Full Text] [Related]

  • 10. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.
    Söderström TS, Poukkula M, Holmström TH, Heiskanen KM, Eriksson JE.
    J Immunol; 2002 Sep 15; 169(6):2851-60. PubMed ID: 12218097
    [Abstract] [Full Text] [Related]

  • 11. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria.
    Zhang XD, Borrow JM, Zhang XY, Nguyen T, Hersey P.
    Oncogene; 2003 May 15; 22(19):2869-81. PubMed ID: 12771938
    [Abstract] [Full Text] [Related]

  • 12. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas.
    Kim S, Kang J, Qiao J, Thomas RP, Evers BM, Chung DH.
    J Pediatr Surg; 2004 Apr 15; 39(4):516-21. PubMed ID: 15065019
    [Abstract] [Full Text] [Related]

  • 13. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX, Kong CZ.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 22; 88(4):271-5. PubMed ID: 18361842
    [Abstract] [Full Text] [Related]

  • 14. NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL).
    Pawlowski JE, Nesterov A, Scheinman RI, Johnson TR, Kraft AS.
    Anticancer Res; 2000 Jan 22; 20(6B):4243-55. PubMed ID: 11205254
    [Abstract] [Full Text] [Related]

  • 15. Tumour necrosis factor-induced activation of c-Jun N-terminal kinase is sensitive to caspase-dependent modulation while activation of mitogen-activated protein kinase (MAPK) or p38 MAPK is not.
    Mohamed AA, Jupp OJ, Anderson HM, Littlejohn AF, Vandenabeele P, MacEwan DJ.
    Biochem J; 2002 Aug 15; 366(Pt 1):145-55. PubMed ID: 11996667
    [Abstract] [Full Text] [Related]

  • 16. Antiapoptotic effects of leptin in human neuroblastoma cells.
    Russo VC, Metaxas S, Kobayashi K, Harris M, Werther GA.
    Endocrinology; 2004 Sep 15; 145(9):4103-12. PubMed ID: 15166121
    [Abstract] [Full Text] [Related]

  • 17. Suppression of extracellular signal-related kinase and activation of p38 MAPK are two critical events leading to caspase-8- and mitochondria-mediated cell death in phytosphingosine-treated human cancer cells.
    Park MT, Choi JA, Kim MJ, Um HD, Bae S, Kang CM, Cho CK, Kang S, Chung HY, Lee YS, Lee SJ.
    J Biol Chem; 2003 Dec 12; 278(50):50624-34. PubMed ID: 14522966
    [Abstract] [Full Text] [Related]

  • 18. Actinomycin D enhances TRAIL-induced caspase-dependent and -independent apoptosis in SH-SY5Y neuroblastoma cells.
    Wang MJ, Liu S, Liu Y, Zheng D.
    Neurosci Res; 2007 Sep 12; 59(1):40-6. PubMed ID: 17707539
    [Abstract] [Full Text] [Related]

  • 19. MAPK signaling is involved in camptothecin-induced cell death.
    Lee S, Lee HS, Baek M, Lee DY, Bang YJ, Cho HN, Lee YS, Ha JH, Kim HY, Jeoung DI.
    Mol Cells; 2002 Dec 31; 14(3):348-54. PubMed ID: 12521296
    [Abstract] [Full Text] [Related]

  • 20. c-Jun N-terminal kinase contributes to apoptotic synergy induced by tumor necrosis factor-related apoptosis-inducing ligand plus DNA damage in chemoresistant, p53 inactive mesothelioma cells.
    Vivo C, Liu W, Broaddus VC.
    J Biol Chem; 2003 Jul 11; 278(28):25461-7. PubMed ID: 12707267
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.